Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

NCT07287189 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy
Duchenne
DMD
Neuromuscular Diseases
Muscular Dystrophies

Interventions

DRUG: SAT-3247
DRUG: Placebo

Sponsor

Satellos Bioscience, Inc.